In The News Posted March 1, 2019 Share Posted March 1, 2019 LAUSANA, Suiza, March 1, 2019 /PRNewswire/ -- - Galderma: Nuevos datos revelan los beneficios de combinar un tratamiento oral y tópico en pacientes con rosácea papulopustular aguda El primer ensayo clínico aleatorio que compara la eficacia y seguridad de una dosis modificada de 40 mg de... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.